Americans are living longer. Mississippi's life expectancy is lower than the national average. Why? Map shows counties where ...

A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.

Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it vulnerable to biosimilar competition in these regions.

The overall economy has proved resilient in recent years, even as many households have struggled. The war with Iran is ...

Health coaching focuses on sustained engagement, helping families build habits over time rather than relying on one-time counseling. This approach also incorporates mental health, stress, sleep, and ...

FDA approval establishes setmelanotide as the first labeled option for acquired hypothalamic obesity, addressing a population ...

A proposed rule first introduced by the USDA in September would expand the range of healthy foods that retailers must stock.

The big pharma company will no longer progress emugrobart to late-stage trials in FSHD and SMA due to a lack of efficacy.

Obesity and loneliness contributed to the morbidity and mortality of COVID-19, but new advances may now address these ...

As use of GLP-1 medications surges, tools like Weight Loss Buddy emerge as critical infrastructure for sustaining ...

Right now, the drugs come with a hefty price tag. Ozempic typically runs 8,800 to 11,000 rupees ($95–$119) per month, while ...

Broad generic availability of semaglutide is not expected until the early 2030s, which means most Americans will stay on branded Ozempic and Wegovy for years to come. Some patients may eye Canadian ...